VALEANT PHARMACEUTICALS INTL
COM · CUSIP 91911K102
2
institutional holders
+0 vs Q4 2021
1.4m
shares reported held*
$31.8mreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $8.3k (-364 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $22.85.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 2 |
| Q1 2020 | 3 |
| Q2 2020 | 3 |
| Q3 2020 | 3 |
| Q4 2020 | 3 |
| Q1 2021 | 3 |
| Q2 2021 | 3 |
| Q3 2021 | 2 |
| Q4 2021 | 2 |
| Q1 2022 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2020 | 1 | 0 |
| Q3 2020 | 1 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 1 |
| Q3 2021 | 0 | 2 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| LeJeune Puetz Investment Counsel LLC | Reduced | -364 |
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| Bruce & Co., Inc. 6.45% of their portfolio | 1.4m $31.6m | Unchanged |
| LeJeune Puetz Investment Counsel LLC 0.10% of their portfolio | 12.4k $283.0k | Reduced -364 |